Gefitinib Accord

Gefitinib Accord is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to therapy.

Gefitinib Accord is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its ability to target cancer cells with EGFR mutations.

Common effects of Gefitinib Accord may include skin rash, diarrhea, and fatigue. Some users may also experience nausea or loss of appetite. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Gefitinib Accord should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication.

Gefitinib Accord may interact with other medications, including those that are metabolized by the liver. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.